BRIEF-Shanghai Fosun Pharma to acquire stake in medical investment firm from Sinopharm

June 26 Thu Jun 26, 2014 8:24am EDT

Related Topics

June 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says to acquire 35 percent stake worth up to 200 million yuan ($32.21 million) in a medical investment firm

* Says to acquire the stake from Sinopharm

Source text in Chinese:

Further company coverage: ($1 = 6.2090 Chinese Yuan Renminbi) (Reporting by Hong Kong and Singapore newsrooms)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.